Carlsquare: Mrkt BUZZ Elicera Therapeutics: Klinisk uppdatering om ELC-100 i linje med våra förväntningar


Igår, 16:10

Carlsquare Equity Research har publicerat en kommentar till den kliniska uppdateringen för ELC-100-programmet.

Läs hela kommentaren här.

Om Carlsquare

Carlsquare is a global research firm and financial advisor focusing on M&A, Equity
Research and Growth Equity. Carlsquare has 170 employees with deep sector knowledge in all 11
GICS sectors. The senior equity research team has extensive experience in the stock
environment and several business sectors. The team produces company research reports,
independent valuations and trading notes. The group have offices in Canada, Denmark, France, Germany, Poland, Sweden, United Kingdom and United States. Read more

www.carlsquare.com

Kontakter

MARKUS AUGUSTSSON
Head of Equity Research
markus.augustsson@carlsquare.com
+46 (0)76 235 03 20

NIKLAS ELMHAMMER
Senior Equity Analyst
niklas.elmhammer@carlsquare.com
+46 (0)70 898 39 59

Bifogade filer

Mrkt BUZZ Elicera Therapeutics: Klinisk uppdatering om ELC-100 i linje med våra förväntningar

Läs mer på MFN



Marknadsöversikt

1 DAG %

Senast

1 mån